Testing for Zika antibodies, specifically IgG and IgM, is crucial for diagnosing a Zika virus infection and managing public health concerns. Testing for Zika antibodies (IgG and IgM) is critical for accurately diagnosing Zika virus infections, differentiating between similar diseases, monitoring public health trends, and managing risks during pregnancy. In areas where Zika virus transmission is prevalent, regular testing can help inform healthcare providers and public health officials, leading to timely interventions and better patient outcomes.
